(Health-NewsWire.Net, September 25, 2017 ) The Asia-Pacific Bio Pharmaceuticals market was worth $30.67 billion in 2016 and estimated to be growing at a CAGR of 10.05%, to reach $49.5 billion by 2021. Asia Pacific is the third largest pharmaceutical market in the world after North America and Europe. Major driver for the pharmaceutical industry in this region is generics, aided by factors such as the aging population and impending expiry of patented drugs.
View Full Report @ http://www.marketdataforecast.com/market-reports/asia-pacific-bio-pharmaceuticals-market-636/
Biopharmaceuticals are medical drugs which can either be produces by biotechnological techniques like recombinant DNA technology or from transgenic plants and animals that are genetically modified. Various diseases such as cancer, diabetes, rheumatoid arthritis, cardiovascular diseases and chronic renal failure are being treated by biopharmaceutical drugs which were non curable with earlier molecular drugs.
Major factors such as technological advancements in biopharmaceuticals, increasing geriatric population, increasing research and development investment and rising incidences of chronic diseases are propelling the market growth. In addition, the ability of biopharmaceuticals to approach a specific target with high efficiency helps in the treatment of various chronic diseases and disorders. However, risk of side-effects and high cost of biopharmaceuticals are restraining the growth of the market.
The Asia-Pacific bio pharmaceuticals market is segmented on the basis of products into Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH). Monoclonal antibodies segment holds the highest number of shares in the product sector. Based on therapeutics, the market is bifurcated into Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and other therapeutic areas. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-bio-pharmaceuticals-market-636/request-sample
Based on geography the market is analysed under various regions namely, China, India, Japan, South Korea and Australia. China leads the market in this region due to highest number of population.
Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc., and Novartis AG are some of the leading players in the market for biopharmaceuticals.
Market Segmentation
1) By Product Type
Monoclonal Antibodies (mAb)
Erythropoietin
Biotech Vaccines
Recombinant Human (RH) Insulin
Granulocyte colony-stimulating factor (G-CSF)
Interferon
Human growth hormones (HGH)
2) By Therapeutic Type
Neurology
Infectious diseases
Diabetes
Oncology
Cardiovascular
Other Therapeutic Areas
Inquire before Buying at http://www.marketdataforecast.com/market-reports/asia-pacific-bio-pharmaceuticals-market-636/inquire
Reasons to buy Asia-Pacific Bio Pharmaceuticals Market Research Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analyzing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|